Zomedica的2025年Q3收入增长16%,达到810万美元,总利润为67%,增长流动资金为5 400万美元。 Zomedica's Q3 2025 revenue rose 16% to $8.1 million, with 67% gross margins and $54 million in liquidity for growth.

Zomedica报告说,2025年第三季度的财务结果显示,收入逐年增加16%,达到810万美元,总利润率达到67%。 Zomedica reported third quarter 2025 financial results showing revenue increased 16% year-over-year to $8.1 million, with gross margins reaching 67%. 该公司还宣布了5 400万美元的流动性,计划利用这些流动资金支持当前的增长举措。 The company also announced $54 million in liquidity, which it plans to use to support ongoing growth initiatives.